Decoy bypass for appetite suppression in obese adults: role of synergistic nutrient sensing receptors GPR84 and FFAR4 on colonic endocrine cells
Madusha Peiris, Rubina Aktar, David Reed, Vincent Cibert-Goton, Ausra Zdanaviciene, Writaja Halder, Adam Robinow, Simon Corke, Harween Dogra, Charles H Knowles, Ashley Blackshaw, Madusha Peiris, Rubina Aktar, David Reed, Vincent Cibert-Goton, Ausra Zdanaviciene, Writaja Halder, Adam Robinow, Simon Corke, Harween Dogra, Charles H Knowles, Ashley Blackshaw
Abstract
Objective: Colonic enteroendocrine cells (EECs) store and release potent anorectic hormones that are key regulators of satiety. EECs express multiple nutrient sensing receptors, particularly for medium-chain fatty acids (MCFAs): GPR84 and FFAR4. Here we show a non-surgical approach with targeted colonic delivery of MCFA, which induces EEC and neuronal activation leading to anorectic effects.
Design: A randomised, double-blind, placebo-controlled, cross-over study was performed in obese adults given combined GPR84 and FFAR4 agonists in colonic release capsules before meals. We measured serum hormones, energy intake and appetite perception. Cell type, activation by agonists and hormone/serotonin release were determined in human colonic explants. Mouse colonic afferent nerve responses to nutrients/mediators were recorded electrophysiologically.
Results: Subjects receiving GPR84 and FFAR4 agonists had reduced overall calorific intake and increased postprandial levels of PYY versus placebo. Receptors including GPR84 and FFAR4 were coexpressed on human colonic EEC. Activation of GPR84 exclusively induced intracellular pERK, whereas FFAR4 selectively activated pCaMKII. Coactivation of GPR84 and FFAR4 induced both phosphoproteins, and superadditive release of GLP-1 and PYY. Nutrients and hormones convergently activated murine colonic afterent nerves via GLP-1, Y2 and 5-HT3 receptors.
Conclusions: Colonic GPR84 and FFAR4 agonists reduce energy intake and increase postprandial PYY in obese adults. Human colonic EECs coexpress these receptors, which activate cells via parallel intracellular pathways and synergistically evoke hormone release. Further synergism occurs in sensory nerve responses to MCFA and EEC mediators. Thus, synergistic activation of colonic endocrine cells via nutrient receptors is an important target for metabolic regulation.
Trail registration number: NCT04292236.
Keywords: appetite; gut hormones; neuroendocrine cells; obesity.
Conflict of interest statement
Competing interests: None declared.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.
Figures
References
- Colquitt JL, Pickett K, Loveman E, et al. . Surgery for weight loss in adults. Cochrane Database Syst Rev 2014:CD003641. 10.1002/14651858.CD003641.pub4
- le Roux CW, Aylwin SJB, Batterham RL, et al. . Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006;243:108–14. 10.1097/01.sla.0000183349.16877.84
- Flynn CR, Albaugh VL, Abumrad NN. Metabolic effects of bile acids: potential role in bariatric surgery. Cell Mol Gastroenterol Hepatol 2019;8:235–46. 10.1016/j.jcmgh.2019.04.014
- Aron-Wisnewsky J, Prifti E, Belda E, et al. . Major microbiota dysbiosis in severe obesity: fate after bariatric surgery. Gut 2019;68:70–82. 10.1136/gutjnl-2018-316103
- Neary NM, Small CJ, Druce MR, et al. . Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology 2005;146:5120–7. 10.1210/en.2005-0237
- Batterham RL, Cohen MA, Ellis SM, et al. . Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 2003;349:941–8. 10.1056/NEJMoa030204
- Turton MD, O'Shea D, Gunn I, et al. . A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1996;379:69–72. 10.1038/379069a0
- Xu Y, Jones JE, Kohno D, et al. . 5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis. Neuron 2008;60:582–9. 10.1016/j.neuron.2008.09.033
- Lieverse RJ, Jansen JB, van de Zwan A, et al. . Effects of a physiological dose of cholecystokinin on food intake and postprandial satiation in man. Regul Pept 1993;43:83–9. 10.1016/0167-0115(93)90410-A
- Nakazato M, Murakami N, Date Y, et al. . A role for ghrelin in the central regulation of feeding. Nature 2001;409:194–8. 10.1038/35051587
- Murphy KG, Bloom SR. Gut hormones and the regulation of energy homeostasis. Nature 2006;444:854–9. 10.1038/nature05484
- Valassi E, Scacchi M, Cavagnini F. Neuroendocrine control of food intake. Nutr Metab Cardiovasc Dis 2008;18:158–68. 10.1016/j.numecd.2007.06.004
- Page AJ, Symonds E, Peiris M, et al. . Peripheral neural targets in obesity. Br J Pharmacol 2012;166:1537–58. 10.1111/j.1476-5381.2012.01951.x
- Gribble FM, Reimann F. Enteroendocrine cells: Chemosensors in the intestinal epithelium. Annu Rev Physiol 2016;78:277–99. 10.1146/annurev-physiol-021115-105439
- Haber AL, Biton M, Rogel N, et al. . A single-cell survey of the small intestinal epithelium. Nature 2017;551:333–9. 10.1038/nature24489
- Gehart H, van Es JH, Hamer K, et al. . Identification of enteroendocrine regulators by real-time single-cell differentiation mapping. Cell 2019;176:e16:1158–73. 10.1016/j.cell.2018.12.029
- Gunawardene AR, Corfe BM, Staton CA. Classification and functions of enteroendocrine cells of the lower gastrointestinal tract. Int J Exp Pathol 2011;92:219–31. 10.1111/j.1365-2613.2011.00767.x
- Symonds EL, Peiris M, Page AJ, et al. . Mechanisms of activation of mouse and human enteroendocrine cells by nutrients. Gut 2015;64:618–26. 10.1136/gutjnl-2014-306834
- Ekberg JH, Hauge M, Kristensen LV, et al. . Gpr119, a major enteroendocrine sensor of dietary triglyceride metabolites Coacting in synergy with FFA1 (GPR40). Endocrinology 2016;157:4561–9. 10.1210/en.2016-1334
- Murtaza B, Hichami A, Khan AS, et al. . Novel GPR120 agonist TUG891 modulates fat taste perception and preference and activates tongue-brain-gut axis in mice. J Lipid Res 2020;61:133–42. 10.1194/jlr.RA119000142
- Sumithran P, Prendergast LA, Delbridge E, et al. . Long-Term persistence of hormonal adaptations to weight loss. N Engl J Med 2011;365:1597–604. 10.1056/NEJMoa1105816
- Dye L, Blundell JE. Menstrual cycle and appetite control: implications for weight regulation. Hum Reprod 1997;12:1142–51. 10.1093/humrep/12.6.1142
- Chambers ES, Viardot A, Psichas A, et al. . Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 2015;64:1744–54. 10.1136/gutjnl-2014-307913
- Flint A, Raben A, Blundell JE, et al. . Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 2000;24:38–48. 10.1038/sj.ijo.0801083
- Ibekwe VC, Khela MK, Evans DF, et al. . A new concept in colonic drug targeting: a combined pH-responsive and bacterially-triggered drug delivery technology. Aliment Pharmacol Ther 2008;28:911–6. 10.1111/j.1365-2036.2008.03810.x
- Brookes SJH, Spencer NJ, Costa M, et al. . Extrinsic primary afferent signalling in the gut. Nat Rev Gastroenterol Hepatol 2013;10:286–96. 10.1038/nrgastro.2013.29
- Berthoud HR, Blackshaw LA, Brookes SJH, et al. . Neuroanatomy of extrinsic afferents supplying the gastrointestinal tract. Neurogastroenterol Motil 2004;16 Suppl 1:28–33. 10.1111/j.1743-3150.2004.00471.x
- Lynn PA, Blackshaw LA. In vitro recordings of afferent fibres with receptive fields in the serosa, muscle and mucosa of rat colon. J Physiol 1999;518:271–82. 10.1111/j.1469-7793.1999.0271r.x
- Daly DM, Park SJ, Valinsky WC, et al. . Impaired intestinal afferent nerve satiety signalling and vagal afferent excitability in diet induced obesity in the mouse. J Physiol 2011;589:2857–70. 10.1113/jphysiol.2010.204594
- Wang J, Wu X, Simonavicius N, et al. . Medium-Chain fatty acids as ligands for orphan G protein-coupled receptor GPR84. J Biol Chem 2006;281:34457–64. 10.1074/jbc.M608019200
- Hudson BD, Shimpukade B, Mackenzie AE, et al. . The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism. Mol Pharmacol 2013;84:710–25. 10.1124/mol.113.087783
- Blackshaw LA, Grundy D. Effects of 5-hydroxytryptamine on discharge of vagal mucosal afferent fibres from the upper gastrointestinal tract of the ferret. J Auton Nerv Syst 1993;45:41–50. 10.1016/0165-1838(93)90360-7
- Bucinskaite V, Tolessa T, Pedersen J, et al. . Receptor-Mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat. Neurogastroenterol Motil 2009;21:978–e78. 10.1111/j.1365-2982.2009.01317.x
- Koda S, Date Y, Murakami N, et al. . The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology 2005;146:2369–75. 10.1210/en.2004-1266
- Dockray GJ. Enteroendocrine cell signalling via the vagus nerve. Curr Opin Pharmacol 2013;13:954–8. 10.1016/j.coph.2013.09.007
- Berthoud HR, Neuhuber WL. Functional and chemical anatomy of the afferent vagal system. Auton Neurosci 2000;85:1–17. 10.1016/S1566-0702(00)00215-0
- Thorens B, Porret A, Bühler L, et al. . Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor. Diabetes 1993;42:1678–82. 10.2337/diab.42.11.1678
- Cox HM, Tough IR, Woolston A-M, et al. . Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses. Cell Metab 2010;11:532–42. 10.1016/j.cmet.2010.04.014
- Worthington JJ, Reimann F, Gribble FM. Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity. Mucosal Immunol 2018;11:3–20. 10.1038/mi.2017.73
- Furness JB. Integrated neural and endocrine control of gastrointestinal function. Adv Exp Med Biol 2016;891:159–73. 10.1007/978-3-319-27592-5_16
- Reimann F, Gribble FM. G protein-coupled receptors as new therapeutic targets for type 2 diabetes. Diabetologia 2016;59:229–33. 10.1007/s00125-015-3825-z
- Mannon PJ, Kanungo A, Mannon RB, et al. . Peptide YY/neuropeptide Y Y1 receptor expression in the epithelium and mucosal nerves of the human colon. Regul Pept 1999;83:11–19. 10.1016/S0167-0115(99)00035-X
- Koehler JA, Baggio LL, Yusta B, et al. . Glp-1R agonists promote normal and neoplastic intestinal growth through mechanisms requiring FGF7. Cell Metab 2015;21:379–91. 10.1016/j.cmet.2015.02.005
- Kapeller J, Möller D, Lasitschka F, et al. . Serotonin receptor diversity in the human colon: expression of serotonin type 3 receptor subunits 5-HT3C, 5-HT3D, and 5-HT3E. J Comp Neurol 2011;519:420–32. 10.1002/cne.22525
- Kristensen M, Jensen MG. Dietary fibres in the regulation of appetite and food intake. Importance of viscosity. Appetite 2011;56:65–70. 10.1016/j.appet.2010.11.147
- Chambers ES, Byrne CS, Morrison DJ, et al. . Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trial. Gut 2019;68:1430–8. 10.1136/gutjnl-2019-318424
- Kentish SJ, O'Donnell TA, Isaacs NJ, et al. . Gastric vagal afferent modulation by leptin is influenced by food intake status. J Physiol 2013;591:1921–34. 10.1113/jphysiol.2012.247577
- Raybould HE, Glatzle J, Robin C, et al. . Expression of 5-HT3 receptors by extrinsic duodenal afferents contribute to intestinal inhibition of gastric emptying. Am J Physiol Gastrointest Liver Physiol 2003;284:G367–72. 10.1152/ajpgi.00292.2001
- Glatzle J, Sternini C, Robin C, et al. . Expression of 5-HT3 receptors in the rat gastrointestinal tract. Gastroenterology 2002;123:217–26. 10.1053/gast.2002.34245
- Grundy D, Hillsley K, Kirkup AJ, et al. . Mesenteric afferent sensitivity to cholecystokinin and 5-hydroxytryptamine. Dtsch Tierarztl Wochenschr 1998;105:466–8.
- Habib AM, Richards P, Cairns LS, et al. . Overlap of endocrine hormone expression in the mouse intestine revealed by transcriptional profiling and flow cytometry. Endocrinology 2012;153:3054–65. 10.1210/en.2011-2170
- Polyviou T, MacDougall K, Chambers ES, et al. . Randomised clinical study: inulin short-chain fatty acid esters for targeted delivery of short-chain fatty acids to the human colon. Aliment Pharmacol Ther 2016;44:662–72. 10.1111/apt.13749
- Ma J, Checklin HL, Wishart JM, et al. . A randomised trial of enteric-coated nutrient pellets to stimulate gastrointestinal peptide release and lower glycaemia in type 2 diabetes. Diabetologia 2013;56:1236–42. 10.1007/s00125-013-2876-2
- Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res 1998;6 Suppl 2:51S-209S.
- Butera PC. Estradiol and the control of food intake. Physiol Behav 2010;99:175–80. 10.1016/j.physbeh.2009.06.010
Source: PubMed